BioDelivery Sciences International Target Lowered to $4 (down 50%)

BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Last Market Price: 1.2, Change: -0.04, % Change: (-3.23%). Shares trade in the range of 1.16 – 1.26 dollars. It has a market capitalization of 35.47M dollars, making it a Small Cap Stock and has 29.56M outstanding shares. The company has a beta of 1.16, indicating, the stock to be more volatile than the market. As per the most recent quarterly report, the net income per share (EPS) is -1.1. It operates in Healthcare sector and belongs to Biotechnology and Drugs industry. Percentage shares held by institutional investors is 41%. The company has a 52 week high of $ 4.05 and a 52 week low of $ 1.16. Average volumes of shares traded daily are 301,692. Volume traded in the last session was at 252,035, 0.84 times the average volume.

• Company had its price target lowered by analysts at Ladenburg Thalmann from $8.00 to $4.00.
• The analysts rate it at a Buy

For Q2 (Jun ’11), It had a Net profit margin of -13273.50%, an Operating margin of -16155.92%. Other Key stats and ratios are : Return on average assets of -53.50%, Return on average equity of -147.29%. The organization has an employee strength of 20

Consensus Recommendation is a Outperform.

Estimate for sales for the Quarter Ending Sep-11 show a mean of 0.60 million dollars, an estimate high of 0.77 million dollars and an estimate low of 0.44 million dollars. A year ago the figures stood at 3.15 million dollars.

Estimate for sales for the Quarter Ending Dec-11 show a mean of 18.04 million dollars, an estimate high of 49.66 million dollars and an estimate low of 1.35 million dollars. A year ago the figures stood at 3.50 million dollars.

Estimate for EPS for the Quarter Ending Sep-11 show a mean of -0.19 dollars, an estimate high of -0.18 dollars and an estimate low of -0.22 dollars. A year ago the figures stood at -0.13 dollars.

Estimate for EPS for the Quarter Ending Dec-11 show a mean of 0.34 dollars, an estimate high of 1.31 dollars and an estimate low of -0.15 dollars. A year ago the figures stood at -0.13 dollars.

Sales for Quarter Ending Jun-11 was estimated at 1.01 million dollars, however the actual sales figure stood at 0.04 million dollars, 0.97 million dollars less than estimates.

Sales for Quarter Ending Mar-11 was estimated at 0.78 million dollars, however the actual sales figure stood at 0.23 million dollars, 0.55 million dollars less than estimates.

Post Written By: Ed Liston Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.